Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rapid characterization of spike variants via mammalian cell surface display
Kamyab Javanmardi, Chia‐Wei Chou, Cynthia I. Terrace, et al.
Molecular Cell (2021) Vol. 81, Iss. 24, pp. 5099-5111.e8
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
William N. Voss, Yixuan J. Hou, Nicole V. Johnson, et al.
Science (2021) Vol. 372, Iss. 6546, pp. 1108-1112
Open Access | Times Cited: 270
Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution
Tyler N. Starr, Allison J. Greaney, William W. Hannon, et al.
Science (2022) Vol. 377, Iss. 6604, pp. 420-424
Open Access | Times Cited: 249
A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike
Bernadeta Dadonaite, Katharine H. D. Crawford, Caelan E. Radford, et al.
Cell (2023) Vol. 186, Iss. 6, pp. 1263-1278.e20
Open Access | Times Cited: 145
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice
Andrew C. Hunt, James Brett Case, Young‐Jun Park, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 646
Open Access | Times Cited: 98
Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion
Song Xue, Yuru Han, Fan Wu, et al.
Protein & Cell (2024) Vol. 15, Iss. 6, pp. 403-418
Open Access | Times Cited: 27
The ins and outs of SARS-CoV-2 variants of concern (VOCs)
Mostafa Salehi‐Vaziri, Mehdi Fazlalipour, Seyed Mahmood Seyed Khorrami, et al.
Archives of Virology (2022) Vol. 167, Iss. 2, pp. 327-344
Open Access | Times Cited: 50
Advances in developing ACE2 derivatives against SARS-CoV-2
Haoran Zhang, Panjing Lv, Jingrui Jiang, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 5, pp. e369-e378
Open Access | Times Cited: 39
Advancing Antibody Engineering through Synthetic Evolution and Machine Learning
Edward B. Irvine, Sai T. Reddy
The Journal of Immunology (2024) Vol. 212, Iss. 2, pp. 235-243
Closed Access | Times Cited: 10
Classical and emerging approximations for the screening of antimicrobial peptide libraries
Cristian F. Rodríguez, Valentina Quezada, Valentina Andrade-Pérez, et al.
Elsevier eBooks (2025), pp. 195-232
Closed Access | Times Cited: 1
Structure-guided engineering of a mutation-tolerant inhibitor peptide against variable SARS-CoV-2 spikes
Shun Nakamura, Yukihiro TANIMURA, Risa Nomura, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 4
Open Access | Times Cited: 1
Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review
Daniele Focosi, Fabrizio Maggi, Massimo Franchini, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 29-29
Open Access | Times Cited: 56
Expression and characterization of SARS-CoV-2 spike proteins
Jeffrey M. Schaub, Chia‐Wei Chou, Hung-Che Kuo, et al.
Nature Protocols (2021) Vol. 16, Iss. 11, pp. 5339-5356
Open Access | Times Cited: 49
Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein
Kamyab Javanmardi, Thomas H. Segall-Shapiro, Chia‐Wei Chou, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 9, pp. 1242-1254.e6
Open Access | Times Cited: 36
mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies
Brian Montoya, Carolina R. Melo‐Silva, Lingjuan Tang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1790-1804
Open Access | Times Cited: 5
Omicron: a drug developer’s perspective
Fang Fang, Pei‐Yong Shi
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 208-211
Open Access | Times Cited: 31
ACE2‐based decoy receptors for SARS coronavirus 2
Wenyang Jing, Erik Procko
Proteins Structure Function and Bioinformatics (2021) Vol. 89, Iss. 9, pp. 1065-1078
Open Access | Times Cited: 28
The mechanisms of immune response and evasion by the main SARS-CoV-2 variants
Qiuli Chen, Jiawei Zhang, Peter Wang, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105044-105044
Open Access | Times Cited: 22
Deep mutagenesis scanning using whole trimeric SARS-CoV-2 spike highlights the importance of NTD-RBD interactions in determining spike phenotype
Ruthiran Kugathasan, Ksenia Sukhova, Maya Moshe, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 8, pp. e1011545-e1011545
Open Access | Times Cited: 13
Computer Simulations and Network-Based Profiling of Binding and Allosteric Interactions of SARS-CoV-2 Spike Variant Complexes and the Host Receptor: Dissecting the Mechanistic Effects of the Delta and Omicron Mutations
Gennady M. Verkhivker, Steve Agajanian, Ryan Kassab, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4376-4376
Open Access | Times Cited: 18
Deep mutational scanning and CRISPR-engineered viruses: tools for evolutionary and functional genomics studies
Mercedes Paz, Gonzalo Moratorio
mSphere (2025)
Open Access
Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering
Gennady M. Verkhivker
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2928-2928
Open Access | Times Cited: 16
Advancements in mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects
Peter Slavny, Manjunath Hegde, Achim Doerner, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Direct Mapping of Polyclonal Epitopes in Serum by HDX-MS
Clint Vorauer, Camila Boniche-Alfaro, Taylor A. Murphree, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 42, pp. 16758-16767
Closed Access | Times Cited: 3
High-throughput screening of spike variants uncovers the key residues that alter the affinity and antigenicity of SARS-CoV-2
Yufeng Luo, Shuo Liu, Jiguo Xue, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Forecasting SARS-CoV-2 spike protein evolution from small data by deep learning and regression
S. B. King, Xinyi E. Chen, Sarah W.S. Ng, et al.
Frontiers in Systems Biology (2024) Vol. 4
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top